Search Results

Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Disease

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation (“the Gates Foundation” or “the foundation”).

April 25, 2024

·

3 min read

Press Releases

Owlstone Medical Enters into a Research Collaboration Agreement with the FDA to Support the Confident Identification of Volatile Organic Compounds on Breath and Expansion of its Breath Biopsy VOC Atlas

September 30, 2024

·

3 min read

Genetown

Owlstone Medical Wins Contract from U.S. Department of Defense to Develop Handheld Breath Biopsy Device for Early Infectious Disease Detection

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, announced that it had won an award from the U.S. Defense Innovation Unit, a division of the U.S. Department of Defense, for ‘Exhaled Breath Diagnostics’.

May 17, 2023

·

2 min read

Business

SQI Diagnostics Inc Signs MOU with UK-Based Owlstone Medical

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), is pleased to announce a Memorandum of Understanding (“MOU”) between SQI and Owlstone Medical to work together on the discovery, development and commercialization of breath-based biomarkers relating to invasive aspergillus lung infection and lung transplant rejection.

January 24, 2022

·

7 min read

Press Releases

Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements

October 28, 2024

·

3 min read

News

Tenon Medical(R) Announces Issuance of Three U.S. Patents

October 18, 2024

·